In 2021, it was approved as Wegovy for chronic weight management
A multi-institutional study in Taiwan by Lin and colleagues found that GLP-1RA users were more likely than sodium-glucose cotransporter 2 inhibitors (SGLT-2I) users to develop PDR or require interventions for DR complications
De Schepper S, Verheijden S, Aguilera-Lizarraga J, et al

Immediate medical attention is necessary if patients experience: Persistent vomiting lasting more than 24 hours or inability to keep down any fluids Signs of dehydration , including decreased urination, dark urine, dizziness, dry mouth, or confusion Severe abdominal pain , particularly if constant, sharp, or radiating to the back (potential pancreatitis) Vomiting blood or material that looks like coffee grounds Signs of gastroparesis , such as feeling full after eating very small amounts, severe bloating, or vomiting undigested food hours after eating Right upper quadrant pain, fever, or yellowing of skin/eyes , which may indicate gallbladder disease (a known risk with GLP-1 receptor agonists) [7] [8] Patients should contact their healthcare provider within 24-48 hours if they experience moderate vomiting that interferes with daily activities, prevents adequate nutrition or medication intake, or does not improve with conservative measures
GLP-1
When B vitamins, magnesium, and fluids run low, even simple tasks feel heavier than they should, so a targeted drip is designed to replenish these reserves quickly and support steadier energy and faster recovery after exertion